Evidence map›Paper›PMID 39158757›Full record

ArticleJapanese journal of ophthalmology2024

Mutations of CYP1B1 and FOXC1 genes for childhood glaucoma in Japanese individuals.

Nobuo Fuse, Masae Kimura, Ai Shimizu, Seizo Koshiba, Teruhiko Hamanaka, Makoto Nakamura, Nobuo Ishida, Hiroshi Sakai, Yoko Ikeda, Kazuhiko Mori and 7 more

Abstract read
In one paragraph

Article in Japanese journal of ophthalmology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nobuo FuseDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan. fusen@megabank.tohoku.ac.jp.ORCID http://orcid.org/0000-0003-0237-4746
Masae KimuraDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Ai ShimizuDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo- machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Seizo KoshibaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Teruhiko HamanakaDepartment of Ophthalmology, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuyaku, 150-8935, Tokyo, Japan.
Makoto NakamuraDivision of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, 650-0017, Kobe, Japan.
Nobuo IshidaIshida Eye Clinic, 2-2-31 Honcho, Joetsu-shi, Niigata, 943-0832, Japan.
Hiroshi SakaiUrasoe Sakai Eye Clinic, 6-1-21 Miyagi, Urasoe, 901-2126, Okinawa, Japan.
Yoko IkedaDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kawaramachi Hirokouji, Kamigyo-ku, Kyoto, 602-0841, Japan.
Kazuhiko MoriDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kawaramachi Hirokouji, Kamigyo-ku, Kyoto, 602-0841, Japan.
Atsushi EndoDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Masao NagasakiDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Fumiki KatsuokaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Jun YasudaDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Yoichi MatsubaraNational Center for Child Health and Development, Research Institute 2-10-1 Okura Setagaya-ku, Tokyo, 157-8535, Japan.
Toru NakazawaDepartment of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo- machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Masayuki YamamotoDepartment of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.

Funding

KAKENHI 19K09927 KAKENHI 19K09927KAKENHI 22K09806 KAKENHI 22K09806
6 · The paper itself

Abstract

purposeTo explore the frequency and positions of genetic mutations in CYP1B1 and FOXC1 in a Japanese population. STUDY

designMolecular genetic analysis.

methodsGenomic DNA was extracted from 31 Japanese patients with childhood glaucoma (CG) from 29 families. We examined the CYP1B, FOXC1, and MYOC genes using Sanger sequencing and whole-exome sequencing (WES).

resultsFor CYP1B1, we identified 9 families that harbored novel mutations, p.A202T, p.D274E, p.Q340*, and p.V420G; the remaining mutations had been previously reported. When mapped to the CYP1B1 protein structure, all mutations appeared to influence the enzymatic activity of CYP1B1 by provoking structural deformity. Five patients were homozygotes or compound heterozygotes, supporting the recessive inheritance of the CYP1B1 mutations in CG. In contrast, four patients were heterozygous for the CYP1B1 mutation, suggesting the presence of regulatory region mutations or strong modifiers. For the FOXC1 gene, we identified 3 novel mutations, p.Q23fs, p.Q70R, and p.E163*, all of which were identified in a heterozygous state. No mutation was found in the MYOC gene in these CG patients. All individuals with CYP1B1 and FOXC1 mutations were severely affected by early-onset CG. In the CYP1B1-, FOXC1-, and MYOC-negative families, we also searched for variants in the other candidate genes reported for CG through WES, but could not find any mutations in these genes.

conclusionsOur analyses of 29 CG families revealed 9 families with point mutations in the CYP1B1 gene, and four of those patients appeared to be heterozygotes, suggesting the presence of complex pathogenic mechanisms. FOXC1 appears to be another major causal gene of CG, indicating that panel sequencing of CYP1B1 and FOXC1 will be useful for diagnosis of CG in Japanese individuals.

Indexed as

Cytochrome P-450 CYP1B1Forkhead Transcription FactorsGlaucomaMutationPedigreeAdolescentChildChild, PreschoolCytoskeletal ProteinsDNADNA Mutational AnalysisEast Asian PeopleExome SequencingEye ProteinsFemaleGlycoproteinsCYP1B1 protein, humanCytochrome P-450 CYP1B1Cytoskeletal ProteinsDNAEye ProteinsForkhead Transcription FactorsFOXC1 protein, humanGlycoproteinsMyocilinChildhood glaucomaCYP1B1 geneFOXC1 genePrimary congenital glaucomaWhole-exome sequencing (WES)

Identifiers

PMID39158757
PMCPMC11607050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.